UnitedHealth Group Incorporated (UNH) Stake Boosted by Nicholas Hoffman & Company LLC.

Nicholas Hoffman & Company LLC. increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.7% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 1,960 shares of the healthcare conglomerate’s stock after buying an additional 52 shares during the period. Nicholas Hoffman & Company LLC.’s holdings in UnitedHealth Group were worth $321,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in UNH. Patriot Financial Group Insurance Agency LLC boosted its stake in shares of UnitedHealth Group by 1,722.9% in the first quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock worth $106,000 after buying an additional 603 shares during the last quarter. Thomas J. Herzfeld Advisors Inc. purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth $111,000. Cribstone Capital Management LLC boosted its stake in shares of UnitedHealth Group by 22.6% in the first quarter. Cribstone Capital Management LLC now owns 678 shares of the healthcare conglomerate’s stock worth $113,000 after buying an additional 125 shares during the last quarter. Israel Discount Bank of New York GFN purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth $139,000. Finally, Parkside Financial Bank & Trust boosted its stake in shares of UnitedHealth Group by 1.4% in the first quarter. Parkside Financial Bank & Trust now owns 854 shares of the healthcare conglomerate’s stock worth $140,000 after buying an additional 12 shares during the last quarter. 86.21% of the stock is currently owned by hedge funds and other institutional investors.

Shares of UnitedHealth Group Incorporated (NYSE UNH) opened at 190.82 on Friday. UnitedHealth Group Incorporated has a 12 month low of $132.39 and a 12 month high of $196.04. The firm has a market capitalization of $184.50 billion, a P/E ratio of 22.92 and a beta of 0.64. The company has a 50 day moving average of $190.49 and a 200-day moving average of $175.87.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, July 18th. The healthcare conglomerate reported $2.46 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.38 by $0.08. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The company had revenue of $50.05 billion during the quarter, compared to analyst estimates of $49.97 billion. During the same quarter in the previous year, the company posted $1.96 earnings per share. UnitedHealth Group’s revenue was up 7.7% compared to the same quarter last year. Analysts predict that UnitedHealth Group Incorporated will post $9.87 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 19th. Shareholders of record on Friday, September 8th will be issued a dividend of $0.75 per share. This represents a $3.00 annualized dividend and a yield of 1.57%. The ex-dividend date is Thursday, September 7th. UnitedHealth Group’s dividend payout ratio is presently 35.13%.

TRADEMARK VIOLATION WARNING: “UnitedHealth Group Incorporated (UNH) Stake Boosted by Nicholas Hoffman & Company LLC.” was originally reported by BNB Daily and is the property of of BNB Daily. If you are reading this news story on another site, it was illegally stolen and republished in violation of United States and international trademark and copyright legislation. The original version of this news story can be read at https://www.baseball-news-blog.com/2017/08/19/nicholas-hoffman-company-llc-increases-position-in-unitedhealth-group-incorporated-unh-updated-updated.html.

Several equities analysts recently commented on UNH shares. Deutsche Bank AG reiterated a “buy” rating and set a $187.00 target price (up from $183.00) on shares of UnitedHealth Group in a research note on Saturday, April 22nd. Jefferies Group LLC reiterated a “buy” rating and set a $192.00 target price (up from $186.00) on shares of UnitedHealth Group in a research note on Saturday, April 22nd. UBS AG reiterated a “buy” rating and set a $194.00 target price (up from $193.00) on shares of UnitedHealth Group in a research note on Saturday, April 22nd. Cantor Fitzgerald reiterated an “overweight” rating and set a $205.00 target price (up from $200.00) on shares of UnitedHealth Group in a research note on Saturday, April 22nd. Finally, Oppenheimer Holdings, Inc. reiterated an “outperform” rating and set a $187.00 target price (up from $186.00) on shares of UnitedHealth Group in a research note on Friday, April 21st. One equities research analyst has rated the stock with a hold rating and twenty-four have issued a buy rating to the company. UnitedHealth Group presently has an average rating of “Buy” and a consensus price target of $203.41.

In other UnitedHealth Group news, Director William C. Ballard, Jr. sold 5,000 shares of the business’s stock in a transaction dated Wednesday, June 7th. The stock was sold at an average price of $182.64, for a total transaction of $913,200.00. Following the completion of the sale, the director now owns 75,735 shares of the company’s stock, valued at $13,832,240.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Gail R. Wilensky sold 5,540 shares of the business’s stock in a transaction dated Friday, June 2nd. The shares were sold at an average price of $178.74, for a total value of $990,219.60. Following the sale, the director now directly owns 60,516 shares of the company’s stock, valued at approximately $10,816,629.84. The disclosure for this sale can be found here. Insiders have sold 15,540 shares of company stock valued at $2,873,320 in the last three months. 0.89% of the stock is currently owned by corporate insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply